These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25485288)

  • 1. The New Classification System for the Dystonias: Why Was it Needed and How was it Developed?
    Jinnah HA; Albanese A
    Mov Disord Clin Pract; 2014 Dec; 1(4):280-284. PubMed ID: 25485288
    [No Abstract]   [Full Text] [Related]  

  • 2. Blink reflex studies in focal dystonias: enhanced excitability of brainstem interneurons in cranial dystonia and spasmodic torticollis.
    Tolosa E; Montserrat L; Bayes A
    Mov Disord; 1988; 3(1):61-9. PubMed ID: 3173365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short latency trigemino-sternocleidomastoid response in muscles in patients with spasmodic torticollis and blepharospasm.
    Quartarone A; Girlanda P; Di Lazzaro V; Majorana G; Battaglia F; Messina C
    Clin Neurophysiol; 2000 Sep; 111(9):1672-7. PubMed ID: 10964081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dystonias: what the practitioner needs to know].
    von Dengler R; Rollnik JD
    MMW Fortschr Med; 2004 Nov; 146(48):44-6. PubMed ID: 15625936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with patients with spasmodic dysphonia and primary Meige syndrome.
    Pedrero-Escalas MF; García-López I; Santiago-Pérez S; Vivancos F; Gavilán J
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(1):1-5. PubMed ID: 29716720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset focal dystonias: To lump or split.
    Jinnah HA; DeFazio G
    Int Rev Neurobiol; 2023; 169():317-327. PubMed ID: 37482396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P; Vécsei L
    Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of focal and generalized dystonia in Rochester, Minnesota.
    Nutt JG; Muenter MD; Aronson A; Kurland LT; Melton LJ
    Mov Disord; 1988; 3(3):188-94. PubMed ID: 3264051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive supranuclear palsy: report of a case with torticollis, blepharospasm, and dysfluency.
    Janati A
    Am J Med Sci; 1986 Dec; 292(6):391-2. PubMed ID: 3799710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients.
    Patel AB; Bansberg SF; Adler CH; Lott DG; Crujido L
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):859-63. PubMed ID: 26024910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of primary focal dystonias in the western area of Tottori prefecture in Japan: Comparison with prevalence evaluated in 1993.
    Fukuda H; Kusumi M; Nakashima K
    Mov Disord; 2006 Sep; 21(9):1503-6. PubMed ID: 16755586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of focal dystonias in the western area of Tottori Prefecture in Japan.
    Nakashima K; Kusumi M; Inoue Y; Takahashi K
    Mov Disord; 1995 Jul; 10(4):440-3. PubMed ID: 7565823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review).
    Yin S; Stucker FJ; Nathan CO
    J La State Med Soc; 2001 Feb; 153(2):92-7. PubMed ID: 11261363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is stuttering a functional dystonia?].
    Le Huche F; Charpy N
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(5):329-32. PubMed ID: 12741296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-pathomorphologic correlations in patients with symptomatic dystonias].
    Ivanović N; Svetel M; Kozić D; Semnic R; Kostić V
    Srp Arh Celok Lek; 2002; 130(5-6):183-8. PubMed ID: 12395440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial dystonia, essential blepharospasm and hemifacial spasm.
    Holds JB; White GL; Thiese SM; Anderson RL
    Am Fam Physician; 1991 Jun; 43(6):2113-20. PubMed ID: 2042553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of dystonia: the Hannover epidemiology study.
    Dressler D; Altenmüller E; Giess R; Krauss JK; Adib Saberi F
    J Neurol; 2022 Dec; 269(12):6483-6493. PubMed ID: 35948800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin in the treatment of neurological disorders.
    Denislic M; Pirtosek Z; Vodusek DB; Zidar J; Meh D
    Ann N Y Acad Sci; 1994 Mar; 710():76-87. PubMed ID: 8154763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.